Therapeutic Application of mRNA for Genetic Diseases
WIREs Nanomedicine and Nanobiotechnology · 2025-05 · 17 (3)
DOI: 10.1002/wnan.70019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 26.05.2025. Verfasst von Paul J L Schürmann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Genetic Therapy, RNA, Messenger, Genetic Diseases, Inborn. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, ERC-2021-STG PRIME, Stichting Metakids, mRNA-research, Koninklijke Nederlandse Akademie van Wetenschappen, KNAW Ammodo Science Award for Groundbreaking Research 2022.
Abstract (Originalsprache)
While gene therapy has been at the center of an active research field for decades, messenger RNA (mRNA) has long been considered unsuited for therapeutic application due to challenges with stability, immunogenicity, and delivery. Where gene therapy focuses on providing the desired genetic code, mRNA can directly provide the instructions encoded in the corresponding gene. This review aims to explore recent advances in mRNA therapies, building on the success of mRNA COVID‐19 vaccines, and extend these insights to the potential treatment of rare genetic diseases. We follow the “outside‐in” trajectory of mRNA therapies from administration to intracellular function, focusing on carrier systems such as lipid nanoparticles and virus‐like particles, mRNA modifications, and the potential and challenges for clinical applications. To treat rare diseases, different approaches can be envisioned, including chronic or acute delivery of mRNAs encoding functional enzymes for enzyme deficiencies and delivery of CRISPR/Cas9–based gene‐editing tools for gene correction. These different approaches determine safety and immunological considerations. By exploring genetic, technical, and therapeutic aspects, this review highlights the potential and current challenges of mRNA therapies to address the large unmet needs in rare genetic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
- Regenerative Medicine Center Utrecht, Utrecht, the Netherlands.
- Erasmus MC Rare Disease Center, Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
- CDL Research, University Medical Center Utrecht, Utrecht, the Netherlands.
- Nanocell Therapeutics, Utrecht, the Netherlands.
ORCID-Profile: Paul J L Schürmann, Stijn P E van Breda Vriesman, Jose A Castro-Alpízar, Sander A A Kooijmans, Raymond M Schiffelers, Sabine A Fuchs
Förderung
- European Research Council, ERC-2021-STG PRIME
- Stichting Metakids, mRNA-research
- Koninklijke Nederlandse Akademie van Wetenschappen, KNAW Ammodo Science Award for Groundbreaking Research 2022
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWA-ORC Research along Routes by Consortia, Netherlands Science Agenda - Research along Routes
- European Research Council
- Stichting Metakids
- Koninklijke Nederlandse Akademie van Wetenschappen
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Schürmann, P. J. L., van Breda Vriesman, S. P. E., Castro-Alpízar, J. A., Kooijmans, S. A. A., Nieuwenhuis, E. E. S., Schiffelers, R. M., & Fuchs, S. A. (2025). Therapeutic Application of mRNA for Genetic Diseases. WIREs Nanomedicine and Nanobiotechnology, 17(3). https://doi.org/10.1002/wnan.70019
Vancouver
Schürmann PJL, van Breda Vriesman SPE, Castro-Alpízar JA, Kooijmans SAA, Nieuwenhuis EES, Schiffelers RM, et al. Therapeutic Application of mRNA for Genetic Diseases. WIREs Nanomedicine and Nanobiotechnology. 2025;17(3). doi:10.1002/wnan.70019
BibTeX
@article{Schrmann2025,
author = {Schürmann, Paul J L and van Breda Vriesman, Stijn P E and Castro-Alpízar, Jose A and Kooijmans, Sander A A and Nieuwenhuis, Edward E S and Schiffelers, Raymond M and Fuchs, Sabine A},
title = {Therapeutic Application of mRNA for Genetic Diseases},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2025},
volume = {17},
number = {3},
doi = {10.1002/wnan.70019}
}
EUVIMED